{"name":"BenevolentAI Bio","slug":"benevolentai-bio","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BEN-2001","genericName":"BEN-2001","slug":"ben-2001","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"BEN-2001","genericName":"BEN-2001","slug":"ben-2001","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxPMVhacVdwVHVVNkdIRXlrTmJCV0lRU3EzdlZLdHZZWlBJT0ZTbDVvNUR4Y3o3cmdGRmtnamhJZEdMc3lybEZteGdrT2pYZUJFYm1WMnoxSUt2ejFJbmU1aGtWd2YtLW9fNFlXU1RZZ3dRbER4bDdBTWJudGFOY3NuUGswcHNrSF80TE80b0Njd3NjTTNQSlFvWXo1V1pEVEQ5elBjYVl4TTZWWXhxbTFOLXBZVU5xaF9BZmNGU3RGVjVHM0V0VEUxMFI3M3g5M0ZhR3lVM19XNUp2VnpubjFOWnRzTzk4cGwwVzJGdFNiZ3pVOUFXLWtDZkx6TkI0clR0OVhKUTdMSFlRdUpKQ3MtY2FCSlV5Y1p3V0lZbjNKOTRQZHFqRXhXTEYzbHc1M3UtMnhIMzBvSUlPVURzcHg5N3BrS1VseUVaVkg5NVQ5TTVSUQ?oc=5","date":"2026-03-04","type":"regulatory","source":"Barchart.com","summary":"Amyotrophic Lateral Sclerosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | COSCIENS Biopharma, BenevolentAI, Verge Genomics, ProJenX - ","headline":"Amyotrophic Lateral Sclerosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOOExZRFJRZ3lheFdmbzVBSmZjTFR4TkJxaGZ2TEhodlZWelVpTVZfQzFkZU1tb3dNZ3dUOTh6dXMtdXVqY1hVQ2N3MS1EMGpIMnlQd0JnYnBqMTJRM201X0x6aU9kaDR1UUFoWUhuWVZlT3g4cEk1aFdicHBGVUVPSjdwcG1Cemd5dFNGc3FBa2c?oc=5","date":"2026-02-09","type":"deal","source":"BioPharma Dive","summary":"Takeda, Iambic partner in latest pharma AI push - BioPharma Dive","headline":"Takeda, Iambic partner in latest pharma AI push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxPTmR3WE1PZ1FPVWRHaXJ2X3VxVlFYNnItTVZyaURZUUFZSjlkYlowMFp5T1RwLU5RbUFmalg5Nm1BNjNueFIzT0RkMVhIMm9wZTdfRjB1NU1xejR6M0J5TkFZSDlEdmNLSTZBVGthYk5YTnZ0LUJtajd2dkdSWkcyUHBSckFtTWxaWGlCX0xoV01VQV96REl5a1dfM2xQTEFpYlkyVllneXVNMWMxaVBDNXI0MjQ0SkdkWmJSSDNMSFlNS1Y0RTZIcTJ2X0VVLUhueGtGMy1pSy1VMk4xcm1wVHRQaWsybDZNd2M1NUYyVnc3YUN4M1VCYmNCV0FLakxhazBV?oc=5","date":"2025-09-18","type":"pipeline","source":"prnewswire.com","summary":"Formation Bio Expands Leadership Team With Top Biotech and Pharma Executives to Accelerate AI-Driven Drug Development - prnewswire.com","headline":"Formation Bio Expands Leadership Team With Top Biotech and Pharma Executives to Accelerate AI-Driven Drug Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPNkVNME96MHdJN2hFajNPZ09hQmNTcjUxZXRVSi1CdllpdDliRkF6eUEyMVN0MjJEY3RXYkE0R0tSR1F3SDBTYi1YRndTMTZpWFNpajBFcjc4MHRCV3EtbHNXU0Y2VWZCZF9xdkV2SmZ1WHFhY21uMElFUWNpY2dsUEk4UV9kanUzbTZDWDFobjhSNUdtT2RyT0tLSkIzVXloLVZIendR?oc=5","date":"2024-12-20","type":"pipeline","source":"The Pharma Letter","summary":"Major overhaul at BenevolentAI includes possible delisting - The Pharma Letter","headline":"Major overhaul at BenevolentAI includes possible delisting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQRGEwWENoOHEwLTdjZDJMa2FhZjA5U3BiUThpU1VzM3pESl9zRFNBdzhxVjA3RzRUTmJiYXJ5RXlyMFhNUmFheUQ1dDNzYmZHZ0lnXzY1Yll2T1VGWEE5cWI3TVdVQXVaR1UyVkk1bzJFZ3pmUG9VVkxVTkdrOG9CMXhfU0hLLXV1VXdTV2R5SG1kSXZtTndTdXp0Sml3SmQ1Tm9qd1RaQjE2SHZKLWxSOG4wRG1vMHVuN19qOVg3WkVZakF0UjFJOE1GLWdtNUlETzVtQ0Nn?oc=5","date":"2024-12-13","type":"pipeline","source":"BioPharma APAC","summary":"25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine - BioPharma APAC","headline":"25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOOUc5R1NFYlJ5cENPZXNVQnNiaTFoeEVWd28yUDdwY2l5alJmRkZndjVsSHZfR1FHYmVYMmUwYkVPQkUyZmV5bExsUmJHVW94LXBvSTJCdHl3UFJnN3BwSVdCZXhqTjBnWlpKaUtlSDNwaUZDU0ZiRjRmMmZxSi0yQ3VCb3B6ZkFSTUFvVE1XNjZENVJGYW5leVFibUFEazhiQW5LRFFQd29rV0Q2bHduZFk1akY5aHhfbkNsRHdKSUw2SWV0bGhMUkdNLV84bFU?oc=5","date":"2024-12-11","type":"pipeline","source":"businesswire.com","summary":"BenevolentAI Unveils Major Strategic Overhaul With Return to Original Mission - businesswire.com","headline":"BenevolentAI Unveils Major Strategic Overhaul With Return to Original Mission","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPc2RaTG5qOEVYU1JtS29yWEpybXpxbGEtVkJOTGhiNGNhcTlUNHBsd0xvdGhEcmkyd0l0NDBLLTNESW56QktfUmU4dGM0MkJJT3c5RlpZZmRSZFlYMm9HYjE4UllzM29IeEhlMU9vVk14OFJzSDJqU3hkWUtabGZDUnM4ZUxnWjRJaHR1RGw4Nm1UX2c?oc=5","date":"2024-12-11","type":"pipeline","source":"MedCity News","summary":"AI Biotech BenevolentAI Restructures Again, This Time to Return to Its TechBio Roots - MedCity News","headline":"AI Biotech BenevolentAI Restructures Again, This Time to Return to Its TechBio Roots","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPdGsxN2NlZjhaYjBHcEtTeEYydThHa3VxQXV4YXhWd0VycXZ2ZkZ1dU12aDZyOWZtakN6bmN0ak9YMjRBTWxHVVpXWFphODNLQnZkTXRJWFJjMVZ1M1ZtVDhjbFhEaUJlZ2Z6cVV1NF9QOUpuYXVhRUtFMG5jN1VVZkVTODBpbUpzVjdJ?oc=5","date":"2024-10-18","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Less than a year in, BenevolentAI CEO is out - Fierce Biotech","headline":"Chutes & Ladders—Less than a year in, BenevolentAI CEO is out","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQNXo5OVZfX2JsbC15ZzBseW5NOFRndDVaX0VSR2NCSEhVdUdfal83Tjc3cFN5WnlSbjVNSFhXYTI1YThwRndOZnQxN3pvVy1IMnNPSDBHcDBDamJydzh0NUx5X2hFRFVzQlFHb1BNTlJCQkpOcGgzVXBfb09aeFNKUFh5djhqbWNBSUVSTWVqbUJ4MENLelFvMlZ3?oc=5","date":"2024-10-06","type":"pipeline","source":"Yahoo Finance","summary":"BenevolentAI: using artificial intelligence to speed up drug discovery - Yahoo Finance","headline":"BenevolentAI: using artificial intelligence to speed up drug discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNdnFCZmd0SmptV3JCcVhtSnRpSDBWRk5MQ19PQmpGSzJsNElGRko5cWpwTlM4N1VrYmpBNUVhTUFhRmJRQ2NOUklfa1hWbnB6RjB0Q0FZMDAtVzg5bHpiRl9VbDVHRVNKNV8zd1FuOHJ6OUs3ek1USmh2bU8tbUhMNmlUVWROMDBIMnNSa3NFTQ?oc=5","date":"2023-09-26","type":"deal","source":"BioPharm International","summary":"BenevolentAI Signs Collaboration with Merck - BioPharm International","headline":"BenevolentAI Signs Collaboration with Merck","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOS3lXZlR2cFFJc2xBRGdiN0NRR2FwMmQxNXJLNEZYM3RPZXdaS2hjRnNuQXVUcERySTJoanB1NkExTWZMYUxPY01aeXNURmY3MFRBNUlOa2hxcktMUkFnQlBZc1VTaVFfQVpMOFZKLW5mNVo4OENFUjJlWXNzVHZ3aFVtb2o3aGs2eGtqVy1KdWxKc3VmY0E?oc=5","date":"2023-05-25","type":"pipeline","source":"BioPharma Dive","summary":"BenevolentAI CFO resigns as company lays off staff, restructures - BioPharma Dive","headline":"BenevolentAI CFO resigns as company lays off staff, restructures","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNRHFiMmZ1TnlRc3FCVDdOWks0aDhmOWFRRTBEYW8ySU9EVlhQWnk3MFp4MTExd2U5OUtDQ2VYS2dwZHJncWlTUHBJY1BsX25uczkyV24wVjJ4NHN4bmN4N0xzbS1DMUZUdngxQ0dnaUw4aFFWcFo4RXF4Tk9FSXVvdmhlR01wMHF2NjNyZVY5d0lKbGNMWGZPWUwtV0RsUFJjNy1IdlA5ckZTVXExVXNvckl0WQ?oc=5","date":"2022-10-10","type":"pipeline","source":"McKinsey & Company","summary":"AI in biopharma research: A time to focus and scale - McKinsey & Company","headline":"AI in biopharma research: A time to focus and scale - McKinsey & Company","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}